UQ researchers use new dosing technology to enhance ICU antibiotic treatment

FHS
March 24, 2024
10:09 am

University of Queensland researchers have used dosing software to accelerate the effects of antibiotics in patients being treated for sepsis in Intensive Care Units.

LOXO-783 by Loxo Oncology for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

Scientists succeed in mapping a central part of the immune system

A new paper in Science Advances details how scientists have succeeded in mapping a central part of the immune system – the HLA class II

November 25, 2023

Opinion | Clean Up the COVID Booster Mess by Returning to a Single-Payer System

Singer is a nurse and a professor of population health. Single-payer health systems make it easier for anyone to access life-saving care at healthcare facilities,

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.